Pulp regeneration after pulpectomy by transplantation of autologous pulp stem cells.
Phase 1
- Conditions
- irreversible pulpitis
- Registration Number
- JPRN-UMIN000009441
- Lead Sponsor
- ational Center for Geriatrics and Gerontology, Research Institute
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 5
Inclusion Criteria
Not provided
Exclusion Criteria
1) patients who have a difficulty in collecting peripheral blood 2) patients who has infection, such as virus, bacteria, fungus or mycoplasma 3) cardiovascular disease patients 4) patients taking anticoagulants or antiplatelet agents 5) diabetes (more than HbA1c 6.1%) 6) osteoporosis 7) pregnant woman, expectant pregnant woman 8) patients who have a past history of allergy with any antimicrobial agent or local anesthetia 9) patients who have a difficulty in getting the consent, such as mentally retarded or mentally illness persons 10) persons to whom the principal investigator of the clinical trial in charge consider to be inappropriate
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method systemic finding oral manifestation extraction socket finding blood test blood chemistry examination Urine chemistry examination periapical swelling tenderness, percussion pain
- Secondary Outcome Measures
Name Time Method electric pulp test radio lucency at the apex psychroalgia, pain to hot and cold, spontaneous pain, tenderness, percussion pain